IONQ · IonQ, Inc.

Current Thesis

IonQ's combined-company guidance restores a measurable revenue story, but the recovery case requires a weekly close above the previously published $44 repair marker before a weekly close below $36 invalidates it. The 2026-09-11 adjusted close was $36.75; price has not confirmed that recovery.

The missing forecast identified on 2026-09-03 has arrived. On 2026-09-08, IonQ issued full-year 2026 revenue guidance of $450–460 million, including SkyWater from its 2026-07-31 acquisition date and eliminating estimated intercompany revenue. The earlier expectation that Investor Day would pass without combined guidance did not materialize. This is management's forecast, not measured revenue. IonQ's filed September 8 announcement.

The narrative leg is commercial quantum growth supported by acquired manufacturing capacity. As an inference, the narrative is saturated — the 2026-09-08 announcement drew renewed analyst coverage on 2026-09-09, yet the 2026-09-11 close remained below the $37.64 close recorded on 2026-09-02. That comparison establishes incomplete price repair; the sample is too small to attribute the decline to Investor Day or establish a durable response pattern.

Bullish and bearish views on IonQ, Inc.

The model's bull view on IonQ, Inc. (IONQ), in brief: Commercial growth preceded consolidation. The bear view: Consolidation complicates growth comparisons. Both cases follow in full.

Bull Case

• Commercial growth preceded consolidation. IonQ's 2026-08-05 results reported second-quarter revenue of $80.05 million, up 287% year over year, with reported organic growth of 132%. Those figures support a commercial-demand argument separate from the subsequent SkyWater consolidation.
• Contracted revenue provides operating evidence. IonQ's second-quarter investor update reported remaining performance obligations of $485 million at 2026-06-30, up 297% year over year. These are contracted obligations, not revenue already recognized.
• Defense demand includes named awards. IonQ's 2026-08-06 announcement disclosed a $28 million DARPA extension for optical atomic clocks and a further $30 million option. The option is contingent; its inclusion in a headline does not establish an exercised award.

Bear Case

• Consolidation complicates growth comparisons. The 2026-09-08 guidance announcement includes acquired revenue and intercompany eliminations without quantifying those components separately. The increase cannot be treated as an organic-growth revision. Filed guidance announcement.
• Operating losses remain substantial. The 2026-08-05 second-quarter results reported an adjusted loss before interest, taxes, depreciation and amortization of $120.3 million. Revenue growth alone does not establish operating profitability.
• Analyst support is not unanimous strengthening. The supplied 2026-09-09 news reports Mizuho retaining Outperform while lowering its price target to $52; Needham maintained $65 and Cantor Fitzgerald maintained $70. These are attributed analyst targets, not evidence that those prices will occur.

Setup & Price Structure

The supplied adjusted daily series records a $36.75 close on 2026-09-11, a three-month decline of 36.5%, and a price 55.2% below the reported 52-week high of $82.09. The 14-day relative strength index was 30.5 on that date. These measurements describe weak recent momentum; they do not establish that a reversal has begun.

The $36 invalidation threshold and $44 repair marker remain the research levels published on 2026-09-03. Neither is presented as a newly verified moving average or support shelf. The available observations do not establish whether an earlier intervening weekly close breached $36; the latest supplied close is above it.

Positioning evidence is dated. The Stock Analysis snapshot recorded on 2026-08-12 showed short interest of 47.05 million shares and 2.14 days to cover. A verified replacement reading is missing, so neither fresh short accumulation nor continuing short covering is established. The analyst headlines clustered on 2026-09-09 measure coverage, not investor flows.

Catalyst Calendar (next 30 days)

• 2026-09-23 through 2026-09-25 — Quantum World Congress. The organizer lists IonQ among its platinum sponsors. Participation establishes a public communications venue, without establishing a scheduled revenue or guidance announcement. Organizer's sponsor announcement.
• 2026-09-24 — Short-interest publication. FINRA's calendar specifies publication for the 2026-09-15 settlement date, providing a positioning observation after Investor Day. It cannot identify individual investors' motives. FINRA reporting calendar.
• 2026-10-09 — Subsequent short-interest publication. FINRA schedules the reading for the 2026-09-30 settlement date. This supplies another observation rather than a standalone test of fundamental demand. FINRA reporting calendar.

A confirmed next earnings date is missing from the available evidence as of 2026-09-13. The elapsed 2026-09-08 Investor Day is no longer an upcoming catalyst.

Elapsed catalysts

• 2026-09-16 — Federal Reserve decision. The Federal Open Market Committee's scheduled meeting concludes on this date. This is a macro event; an IonQ-specific response cannot be inferred from the calendar. Federal Reserve September calendar. (passed 4d ago)

What Would Change Our Mind

Failure of the retained $36 threshold ends the recovery case: a weekly close below $36 is the gradeable price invalidation. A subsequent reduction of management's 2026-09-08 full-year revenue outlook below its $450 million lower bound would independently break the revenue premise.

The positive resolution is a weekly close above the previously published $44 repair marker while the combined guidance remains intact, occurring before the price invalidation. Conviction remains low because the 2026-09-11 close of $36.75 has not demonstrated that repair despite the forecast's publication.

Correlation Notes

This is a single-name recovery thesis. IonQ's presence alongside other quantum companies at the 2026-09-23–25 Quantum World Congress establishes shared exposure to conference headlines, not measured stock-return correlation. Quantum World Congress.

No dated peer-return series or current correlation estimate accompanies the 2026-09-11 price observations. The evidence therefore does not support a claim that a quantum-sector advance will resolve IonQ's structure; the published price conditions remain company-specific.